Anna-Lena Spetz
![Anna-Lena Spetz Anna-Lena Spetz](https://dermatology-drugdevelopment-europe.com/wp-content/uploads/sites/42/2023/11/Anna-Lena-Spetz-150x150.jpg)
Company: TIRmed
Job title: Chief Scientific Officer & founder
Seminars:
Development of a Topical Containing a Non-Coding Oligonucleotide 9:45 am
• Proof-of-concept study in canines with atopic dermatitis • Cutaneous CD11b+ cells that inhibit Th1/2/9 responses and promote Tregs are recruited by a non-coding oligonucleotide • Upregulation of immune-checkpoint proteins on cutaneous CD11b+ cellsRead more
day: Day Two